During the past decade, Fürst Stirum Klinik Bruchsal conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fürst Stirum Klinik Bruchsal" #1 collaborator was "Central European Society for Anticancer Drug Research" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Fürst Stirum Klinik Bruchsal" are "Atrial Fibrillation" (1 trials), "Colon Cancer" (1 trials) and "Peripheral Artery Disease" (1 trials). Many other conditions were trialed in "Fürst Stirum Klinik Bruchsal" in a lesser frequency.

Most popular intervention types in "Fürst Stirum Klinik Bruchsal" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Edoxaban" (1 trials), "LifeStent Vascular Stent" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fürst Stirum Klinik Bruchsal" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fürst Stirum Klinik Bruchsal". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fürst Stirum Klinik Bruchsal, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fürst Stirum Klinik Bruchsal, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".